MHUAF
Meihua International Medical Technologies Co., Ltd.
Price Chart
Latest Quote
$7.25
-1.11 (-13.28%)
Current Price
| Previous Close | $8.36 |
| Open | $8.40 |
| Day High | $8.40 |
| Day Low | $7.25 |
| Volume | 302 |
Stock Information
| Shares Outstanding | 856K |
| Total Debt | $8.99M |
| Cash Equivalents | $15.15M |
| Revenue | $61.79M |
| Net Income | $6.78M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $6.20M |
| P/E Ratio | 0.40 |
| EPS (TTM) | $18.04 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-344K |
| Sales | $61.79M |
| Income | $6.78M |
| Book/sh | $271.61 |
| Cash/sh | $17.71 |
| Employees | 486 |
Financial Ratios
| Quick Ratio | 6.19 |
| Current Ratio | 8.41 |
| Debt/Eq | 4.76 |
| EPS Growth TTM | -40.60% |
Returns & Margins
| ROA | 2.63% |
| ROE | 3.90% |
| Gross Margin | 30.95% |
| Operating Margin | 21.19% |
| Profit Margin | 10.97% |
Ownership
| Insider Ownership | 18.57% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.10 |
| P/B | 0.03 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $8.29 |
| SMA50 | $8.39 |
| SMA200 | $14.68 |
| RSI | 30.77 |
| ATR | 0.2157 |
| Shares Float | 566K |
| Short Float | 0.66% |
| Short Ratio | 0.42 |
| Volatility | 0.92 |
| Rel Volume | 0.42 |
Performance History
| Week | -12.65% |
| Month | -14.20% |
| Quarter | -9.38% |
| 6 Months | +53.28% |
| YTD | +253.66% |
| Year | -82.74% |
| 3 Years | -97.32% |
| 10 Years | -99.44% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $7.25 | 302 |
| 2026-06-23 | $8.37 | 300 |
| 2026-06-22 | $8.36 | 400 |
| 2026-06-18 | $8.35 | 300 |
| 2026-06-17 | $8.35 | 700 |
| 2026-06-16 | $8.30 | 400 |
| 2026-06-15 | $8.10 | 600 |
| 2026-06-12 | $8.30 | 400 |
| 2026-06-11 | $8.30 | 400 |
| 2026-06-10 | $8.00 | 900 |
| 2026-06-09 | $8.40 | 900 |
| 2026-06-08 | $8.50 | 800 |
| 2026-06-05 | $8.70 | 1,400 |
| 2026-06-04 | $8.35 | 600 |
| 2026-06-03 | $8.40 | 1,100 |
| 2026-06-02 | $8.45 | 800 |
| 2026-06-01 | $8.40 | 1,200 |
| 2026-05-29 | $8.40 | 1,100 |
| 2026-05-28 | $8.20 | 1,300 |
| 2026-05-27 | $8.40 | 500 |
| 2026-05-26 | $8.40 | 800 |
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China, Europe, North America, South America, Asia, Africa, and Oceania. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, disposable bracelet, tube cleaning brush, gynecological examination and sterile surgical dressing kits, medical hand scrub, cervical sampling swab, catheter, hand washing brush, cervical liquid based cell sampler, surgical hats, suction connecting tube, nasal oxygen tube, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; medical devices, such as medical x-ray films and multi-functional self-extracting X-ray film machines; and provides SaaS development service to develop customized SaaS system covering the entire project lifecycle, including demand analysis, design, research and development, testing, launch, and maintenance support. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. The company was founded in 1991 and is headquartered in Yangzhou, the People's Republic of China.
đ° Latest News
No news articles available at the moment. Check back later for updates on MHUAF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $63,215,599 | $63,610,121 | $65,247,864 | $63,784,469 |
| Cost Of Revenue | $63,609,840 | $63,900,597 | $65,247,864 | $64,232,469 |
| Total Revenue | $96,909,642 | $97,098,915 | $103,346,341 | $104,037,710 |
| Operating Revenue | $96,909,642 | $97,098,915 | $103,346,341 | $104,037,710 |
| Expenses | ||||
| Interest Expense | $1,506,700 | $250,781 | $194,667 | $180,744 |
| Total Expenses | $82,597,727 | $82,423,977 | $87,788,843 | $77,776,756 |
| Rent Expense Supplemental | $6,765 | $7,753 | $7,515 | $20,349 |
| Other Income Expense | $-193,486 | $-248,822 | $-4,535,309 | $123,976 |
| Other Non Operating Income Expenses | $-573,740 | $-95,382 | $-53,205 | $-50,437 |
| Net Non Operating Interest Income Expense | $-492,298 | $622,658 | $-130,942 | $-156,889 |
| Interest Expense Non Operating | $1,506,700 | $250,781 | $194,667 | $180,744 |
| Operating Expense | $18,987,887 | $18,523,380 | $22,540,979 | $13,544,287 |
| Other Operating Expenses | $93,140 | $103,317 | $129,425 | $126,650 |
| Selling And Marketing Expense | $5,272,076 | $5,151,644 | $7,109,524 | $5,170,365 |
| General And Administrative Expense | $8,250,976 | $7,815,825 | $12,468,551 | $4,692,106 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $10,843,589 | $11,625,417 | $6,242,969 | $20,949,579 |
| Net Interest Income | $-492,298 | $622,658 | $-130,942 | $-156,889 |
| Interest Income | $1,014,402 | $873,439 | $63,725 | $23,855 |
| Normalized Income | $10,541,161 | $11,743,601 | $9,604,547 | $20,810,267 |
| Net Income From Continuing And Discontinued Operation | $10,843,589 | $11,625,417 | $6,242,969 | $20,949,579 |
| Total Operating Income As Reported | $14,311,915 | $14,674,938 | $10,801,962 | $26,260,954 |
| Net Income Common Stockholders | $10,843,589 | $11,625,417 | $6,242,969 | $20,949,579 |
| Net Income | $10,843,589 | $11,625,417 | $6,242,969 | $20,949,579 |
| Net Income Including Noncontrolling Interests | $10,837,307 | $11,591,041 | $6,177,704 | $20,949,579 |
| Net Income Continuous Operations | $10,837,307 | $11,591,041 | $6,177,704 | $20,949,579 |
| Pretax Income | $13,626,131 | $15,048,774 | $10,891,247 | $26,228,041 |
| Special Income Charges | $0 | $0 | $-4,755,536 | $0 |
| Interest Income Non Operating | $1,014,402 | $873,439 | $63,725 | $23,855 |
| Operating Income | $14,311,915 | $14,674,938 | $15,557,498 | $26,260,954 |
| Depreciation Amortization Depletion Income Statement | $176,794 | $180,517 | $126,491 | $174,473 |
| Depreciation And Amortization In Income Statement | $176,794 | $180,517 | $126,491 | $174,473 |
| Amortization Of Intangibles Income Statement | $26,973 | $62,149 | $22,196 | $26,951 |
| Depreciation Income Statement | $149,821 | $118,368 | $104,295 | $147,522 |
| Gross Profit | $33,299,802 | $33,198,318 | $38,098,477 | $39,805,241 |
| Per Share | ||||
| Diluted EPS | $40.00 | $49.00 | $27.00 | $0.80 |
| Basic EPS | $40.00 | $49.00 | $27.00 | $0.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $77,826 | $-35,256 | $-1,120,526 | $35,101 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $15,323,612 | $15,923,988 | $16,131,479 | $26,856,845 |
| Total Unusual Items | $380,254 | $-153,440 | $-4,482,104 | $174,413 |
| Total Unusual Items Excluding Goodwill | $380,254 | $-153,440 | $-4,482,104 | $174,413 |
| Reconciled Depreciation | $571,035 | $470,993 | $563,461 | $622,473 |
| EBITDA (Bullshit earnings) | $15,703,866 | $15,770,548 | $11,649,375 | $27,031,258 |
| EBIT | $15,132,831 | $15,299,555 | $11,085,914 | $26,408,785 |
| Diluted Average Shares | $273,717 | $239,400 | $234,110 | $25,000,000 |
| Basic Average Shares | $273,717 | $239,400 | $234,110 | $25,000,000 |
| Diluted NI Availto Com Stockholders | $10,843,589 | $11,625,417 | $6,242,969 | $20,949,579 |
| Minority Interests | $6,282 | $34,376 | $65,265 | $0 |
| Tax Provision | $2,788,824 | $3,457,733 | $4,713,543 | $5,278,462 |
| Write Off | $0 | $0 | $4,755,536 | $0 |
| Gain On Sale Of Security | $380,254 | $-153,440 | $273,432 | $174,413 |
| Other Taxes | $629,456 | $585,101 | $642,748 | $655,679 |
| Provision For Doubtful Accounts | $1,109,347 | $1,933,661 | $0 | $0 |
| Amortization | $26,973 | $62,149 | $22,196 | $26,951 |
| Research And Development | $3,456,098 | $2,753,315 | $2,962,904 | $2,725,014 |
| Selling General And Administration | $13,523,052 | $12,967,469 | $19,578,075 | $9,862,471 |
| Other Gand A | $5,455,471 | $4,888,827 | $12,468,551 | $2,147,350 |
| Insurance And Claims | $5,067 | $115,723 | $108,146 | $9,743 |
| Rent And Landing Fees | $6,765 | $7,753 | $7,515 | $20,349 |
| Salaries And Wages | $2,783,673 | $2,803,522 | $2,831,050 | $2,514,664 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $158,532,512 | $142,415,923 | $137,625,337 | $89,945,201 |
| Total Assets | $186,239,116 | $171,915,272 | $163,577,579 | $136,857,381 |
| Total Non Current Assets | $42,800,794 | $39,678,219 | $28,258,424 | $39,581,031 |
| Other Non Current Assets | $11,088,736 | $11,267,764 | $12,333,122 | - |
| Non Current Prepaid Assets | $0 | $9,155,059 | $0 | - |
| Non Current Deferred Assets | $992,904 | $369,483 | $0 | - |
| Non Current Deferred Taxes Assets | $992,904 | $369,483 | $0 | - |
| Goodwill And Other Intangible Assets | $443,035 | $3,915,917 | $497,600 | $17,823,401 |
| Other Intangible Assets | $443,035 | $3,915,917 | $497,600 | $17,823,401 |
| Current Assets | $143,438,322 | $132,237,053 | $135,319,155 | $97,276,350 |
| Other Current Assets | $9,740,424 | $14,212,606 | $16,428,779 | $1,394,539 |
| Restricted Cash | $1,328,895 | $1,366,216 | - | - |
| Inventory | $1,409,639 | $1,617,225 | $1,122,038 | $1,251,393 |
| Receivables | $114,999,307 | $99,480,344 | $91,031,638 | $86,481,142 |
| Notes Receivable | $18,566,258 | $20,431,900 | $22,085,846 | $19,379,845 |
| Accounts Receivable | $79,387,880 | $79,027,317 | $68,945,792 | $67,101,297 |
| Allowance For Doubtful Accounts Receivable | $-2,969,406 | $-1,928,486 | $0 | - |
| Gross Accounts Receivable | $82,357,286 | $80,955,803 | $68,945,792 | - |
| Cash Cash Equivalents And Short Term Investments | $15,960,057 | $15,560,662 | $26,736,700 | $8,149,276 |
| Cash And Cash Equivalents | $15,960,057 | $15,560,662 | $26,736,700 | $8,149,276 |
| Cash Financial | $15,960,057 | $15,560,662 | $26,736,700 | $8,149,276 |
| Current Deferred Assets | - | - | - | $1,394,539 |
| Debt | ||||
| Total Debt | $7,945,966 | $7,331,134 | $6,814,360 | $5,178,420 |
| Long Term Debt And Capital Lease Obligation | $0 | $4,592 | $724,932 | - |
| Current Debt And Capital Lease Obligation | $7,945,966 | $7,326,542 | $6,089,428 | $5,178,420 |
| Current Debt | $7,945,966 | $7,324,047 | $6,089,428 | $5,178,420 |
| Long Term Debt | - | - | $724,932 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $27,263,569 | $25,077,450 | $24,898,499 | $29,088,779 |
| Total Non Current Liabilities Net Minority Interest | $0 | $4,592 | $724,932 | $0 |
| Current Liabilities | $27,263,569 | $25,072,858 | $24,173,567 | $29,088,779 |
| Other Current Liabilities | $1,328,895 | - | - | - |
| Payables And Accrued Expenses | $17,988,708 | $17,746,316 | $18,084,139 | $23,910,359 |
| Payables | $16,718,800 | $16,904,160 | $17,227,441 | $23,063,293 |
| Total Tax Payable | $1,243,127 | $1,082,131 | $1,131,276 | $2,082,252 |
| Income Tax Payable | $787,848 | $672,245 | $690,824 | $1,521,767 |
| Accounts Payable | $15,475,673 | $15,822,029 | $16,096,165 | $20,981,041 |
| Equity | ||||
| Common Stock Equity | $158,975,547 | $146,331,840 | $138,122,937 | $107,768,602 |
| Total Equity Gross Minority Interest | $158,975,547 | $146,837,822 | $138,679,080 | $107,768,602 |
| Stockholders Equity | $158,975,547 | $146,331,840 | $138,122,937 | $107,768,602 |
| Gains Losses Not Affecting Retained Earnings | $4,711,452 | $8,716,975 | $11,813,722 | $20,467,455 |
| Other Equity Adjustments | $4,711,452 | $8,716,975 | $11,813,722 | $20,467,455 |
| Retained Earnings | $105,226,822 | $94,635,889 | $83,330,239 | $77,574,663 |
| Other | ||||
| Ordinary Shares Number | $31,904,468 | $23,940,000 | $23,940,000 | $25,000,000 |
| Share Issued | $31,904,468 | $23,940,000 | $23,940,000 | $25,000,000 |
| Tangible Book Value | $158,532,512 | $142,415,923 | $137,625,337 | $89,945,201 |
| Invested Capital | $166,921,513 | $153,655,887 | $144,937,297 | $112,947,022 |
| Working Capital | $116,174,753 | $107,164,195 | $111,145,588 | $68,187,571 |
| Capital Lease Obligations | $0 | $7,087 | $0 | - |
| Total Capitalization | $158,975,547 | $146,331,840 | $138,847,869 | $107,768,602 |
| Minority Interest | $0 | $505,982 | $556,143 | $0 |
| Treasury Stock | $200,000 | $0 | - | - |
| Additional Paid In Capital | $49,221,322 | $42,967,006 | $42,967,006 | $9,716,484 |
| Capital Stock | $15,951 | $11,970 | $11,970 | $10,000 |
| Common Stock | $15,951 | $11,970 | $11,970 | $10,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $4,592 | $0 | - |
| Current Capital Lease Obligation | $0 | $2,495 | $0 | - |
| Line Of Credit | $7,945,966 | $7,324,047 | $6,089,428 | $5,178,420 |
| Current Accrued Expenses | $1,269,908 | $842,156 | $856,698 | $847,066 |
| Investments And Advances | $22,389,540 | $6,131,941 | $6,669,655 | $941,531 |
| Net PPE | $7,886,579 | $8,838,055 | $8,758,047 | $20,816,099 |
| Accumulated Depreciation | $-4,283,474 | $-3,860,391 | $-3,777,301 | $-6,585,363 |
| Gross PPE | $12,170,053 | $12,698,446 | $12,535,348 | $27,401,462 |
| Construction In Progress | $0 | $134,578 | $1,394,146 | $13,996,235 |
| Other Properties | $327,787 | $344,079 | $343,849 | $333,688 |
| Machinery Furniture Equipment | $2,756,428 | $2,885,066 | $3,453,861 | $3,518,839 |
| Buildings And Improvements | $9,085,838 | $9,334,723 | $7,343,492 | $9,552,700 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $631,367 | $1,048,211 | $560,119 | $682,699 |
| Work In Process | $4,472 | $2,376 | $343,795 | $224,694 |
| Raw Materials | $773,800 | $566,638 | $218,124 | $344,000 |
| Duefrom Related Parties Current | $17,045,169 | $21,127 | $0 | $0 |
| Treasury Shares Number | - | $0 | - | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $14,503,255 | $-2,410,832 | $-11,861,767 | $-904,894 |
| Operating Activities | ||||
| Operating Cash Flow | $14,636,805 | $2,275,750 | $-9,163,038 | $-54,663 |
| Cash Flow From Continuing Operating Activities | $14,636,805 | $2,275,750 | $-9,163,038 | $-54,663 |
| Operating Gains Losses | $-495,686 | $250,927 | $-248,409 | $15,281 |
| Investing Activities | ||||
| Capital Expenditure | $-133,550 | $-4,686,582 | $-2,698,729 | $-850,231 |
| Investing Cash Flow | $-20,421,028 | $-12,458,698 | $-8,620,292 | $-833,817 |
| Cash Flow From Continuing Investing Activities | $-20,421,028 | $-12,458,698 | $-8,620,292 | $-833,817 |
| Net Other Investing Changes | $-17,290,577 | $-9,179,624 | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-200,000 | - | - | - |
| Issuance Of Capital Stock | $0 | $0 | $34,529,644 | $0 |
| Financing Cash Flow | $6,213,831 | $706,125 | $37,245,500 | $1,860,234 |
| Cash Flow From Continuing Financing Activities | $6,213,831 | $706,125 | $37,245,500 | $1,860,234 |
| Net Common Stock Issuance | $-200,000 | $0 | $34,529,644 | $0 |
| Common Stock Issuance | $0 | $0 | $34,529,644 | $0 |
| Net Other Financing Charges | - | - | $635,310 | - |
| Other | ||||
| Repayment Of Debt | $-9,728,032 | $-5,931,449 | $-6,241,641 | $-4,650,586 |
| Issuance Of Debt | $16,141,863 | $6,637,574 | $8,322,187 | $6,510,820 |
| Interest Paid Supplemental Data | $247,615 | $250,781 | $194,667 | $180,744 |
| Income Tax Paid Supplemental Data | $3,657,394 | $3,583,143 | $5,703,288 | $5,042,816 |
| End Cash Position | $17,288,952 | $16,926,878 | $26,736,700 | $8,149,276 |
| Beginning Cash Position | $16,926,878 | $26,736,700 | $8,149,276 | $7,187,334 |
| Effect Of Exchange Rate Changes | $-67,534 | $-332,999 | $-874,746 | $-9,812 |
| Changes In Cash | $429,608 | $-9,476,823 | $19,462,170 | $971,754 |
| Common Stock Payments | $-200,000 | - | - | - |
| Net Issuance Payments Of Debt | $6,413,831 | $706,125 | $2,080,546 | $1,860,234 |
| Net Short Term Debt Issuance | $6,413,831 | $706,125 | $1,337,494 | $1,860,234 |
| Short Term Debt Payments | $-9,728,032 | $-5,931,449 | $-6,241,641 | $-4,650,586 |
| Short Term Debt Issuance | $16,141,863 | $6,637,574 | $7,579,135 | $6,510,820 |
| Net Long Term Debt Issuance | $0 | $0 | $743,052 | $0 |
| Long Term Debt Issuance | $0 | $0 | $743,052 | $0 |
| Net Investment Purchase And Sale | $-4,296,901 | $353,062 | $-5,944,709 | $0 |
| Sale Of Investment | $567,115 | $353,062 | $0 | $0 |
| Purchase Of Investment | $-4,864,016 | $0 | $-5,944,709 | $0 |
| Net Business Purchase And Sale | $-89,719 | - | - | - |
| Purchase Of Business | $-89,719 | - | - | - |
| Net Intangibles Purchase And Sale | $0 | $-3,503,883 | $0 | $0 |
| Purchase Of Intangibles | $0 | $-3,503,883 | $0 | $0 |
| Net PPE Purchase And Sale | $1,256,169 | $-128,253 | $-2,675,583 | $-833,817 |
| Sale Of PPE | $1,389,719 | $1,054,446 | $23,146 | $16,414 |
| Purchase Of PPE | $-133,550 | $-1,182,699 | $-2,698,729 | $-850,231 |
| Change In Working Capital | $-27,971 | $-11,600,397 | $-20,411,330 | $-21,641,996 |
| Change In Other Current Liabilities | $-627 | $-611 | $0 | $0 |
| Change In Payables And Accrued Expense | $1,717,135 | $178,920 | $-4,107,808 | $5,317,720 |
| Change In Accrued Expense | $596,218 | $9,911 | $75,879 | $120,090 |
| Change In Payable | $1,120,917 | $169,009 | $-4,183,687 | $5,197,630 |
| Change In Account Payable | $932,491 | $185,902 | $-3,371,275 | $4,908,971 |
| Change In Tax Payable | $188,426 | $-16,893 | $-812,412 | $288,659 |
| Change In Income Tax Payable | $188,426 | $-16,893 | $-812,412 | $288,659 |
| Change In Prepaid Assets | $1,304,710 | $1,760,865 | $-4,932,145 | $-861,799 |
| Change In Inventory | $165,759 | $-528,635 | $35,027 | $105,121 |
| Change In Receivables | $-3,214,948 | $-13,010,936 | $-11,406,404 | $-26,203,038 |
| Changes In Account Receivables | $-4,541,264 | $-14,015,900 | $-7,121,889 | $-20,065,904 |
| Other Non Cash Items | $3,285,408 | - | - | - |
| Provisionand Write Offof Assets | $1,109,347 | $1,933,661 | $0 | $0 |
| Asset Impairment Charge | $0 | $0 | $4,755,536 | $0 |
| Deferred Tax | $-642,635 | $-370,475 | $0 | $0 |
| Deferred Income Tax | $-642,635 | $-370,475 | $0 | $0 |
| Depreciation Amortization Depletion | $571,035 | $470,993 | $563,461 | $622,473 |
| Depreciation And Amortization | $571,035 | $470,993 | $563,461 | $622,473 |
| Amortization Cash Flow | $26,973 | $62,149 | $22,196 | $26,951 |
| Amortization Of Intangibles | $26,973 | $62,149 | $22,196 | $26,951 |
| Depreciation | $544,062 | $408,844 | $541,265 | $595,522 |
| Earnings Losses From Equity Investments | $-94,183 | $-4,832 | $0 | $0 |
| Net Foreign Currency Exchange Gain Loss | $-380,254 | $153,440 | $-273,432 | $0 |
| Gain Loss On Sale Of PPE | $111 | $102,319 | $25,023 | $15,281 |
| Gain Loss On Sale Of Business | $-21,360 | $0 | $0 | - |
| Net Income From Continuing Operations | $10,837,307 | $11,591,041 | $6,177,704 | $20,949,579 |
| Change In Other Working Capital | - | - | - | $-861,799 |
Fetched: 2026-02-02